MC
CVS icon

Matisse Capital’s CVS Health CVS Stock Holding History

Matisse Capital’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-8,391
Closed -$496K – 182
2024
Q2 		$496K Hold
8,391
– – 0.25% 116
2024
Q1 		$669K Hold
8,391
– – 0.32% 96
2023
Q4 		$663K Hold
8,391
– – 0.35% 97
2023
Q3 		$586K Hold
8,391
– – 0.41% 92
2023
Q2 		$580K Hold
8,391
– – 0.36% 99
2023
Q1 		$624K Buy
+8,391
New +$704K 0.4% 90
2019
Q1 		– Sell
-4,727
Closed -$310K – 101
2018
Q4 		$310K Buy
+4,727
New +$353K 0.39% 62

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Matisse Capital's CVS Position: Q3 2024 in Review

Matisse Capital sold out of CVS Health (CVS) in Q3 2024, closing a stake of 8,391 shares — an estimated $496K sold.

Matisse Capital first reported a position in CVS in Q4 2018 and held it in 7 quarters. The position peaked at $669K in Q1 2024. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

  • Matisse Capital reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
  • Matisse Capital sold 8,391 CVS Health shares in Q3 2024, an estimated $496K.
  • Matisse Capital first reported a position in CVS Health in Q4 2018 and held it in 7 quarters.
  • Matisse Capital's CVS Health position peaked at $669K in Q1 2024.
  • 1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Matisse Capital's 13F filing for Q3 2024, filed 17 Oct 2024.